Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide as Add-on to Levodopa in Advanced PD (SETTLE)
NCT00627640Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Feb 2009; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00627640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627640.